Advertorial

Elevating pharmaceutical manufacturing processes with real-time insights

By

4 December 2023

Shares

8

Share this post

(Bio)pharmaceutical manufacturing is changing considerably, with key innovations enabling companies to rethink R&D, manufacturing, quality control and quality assurance (QC/QA) operations. The spotlight is squarely on process analytical technology (PAT), which underpins the successful transition towards highly effective advanced manufacturing strategies. Martin Gadsby, Chairman of Optimal Industrial Technologies, looks at how this transformative approach is making advanced manufacturing practices more accessible thanks to the latest developments in instrumentation and data-oriented solutions.

The (bio)pharmaceutical industry is currently facing numerous hurdles in its path to high-efficiency production that are more complex and pressing than ever before. One of the most significant perceived challenges is the ability to implement new innovations and increase productivity while adhering to stringent regulatory demands. The race to develop new drugs and therapies demands rapid drug discovery, testing and time-to-market. To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput. Simultaneously, there is increasing need for stringent quality control and traceability throughout the supply chain to ensure patient safety.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

PAT has emerged as a game-changer to drive performance, traceability and regulatory compliance, helping the sector overcome current limitations and embrace new strategies while futureproofing it in line with Industry 4.0 principles. This is a systematic approach that harnesses the power of data and leverages real-time analysis tools to closely monitor and control critical process parameters (CPPs) and their relationship with critical quality attributes (CQAs). As a result, PAT enhances process understanding and regulatory compliance while ensuring consistent product quality. More precisely, real-time monitoring allows for meticulous scrutiny of data against predefined parameters. Should the need arise, adjustments to the process can be seamlessly made either manually or automatically, ensuring the production of high-quality goods with unmatched efficiency.

Download the full feature partnership to learn more…

Share via